A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
This study has been completed.
Sponsor:
Janssen-Cilag International NV
Information provided by:
Janssen-Cilag International NV
ClinicalTrials.gov Identifier:
NCT00566631
First received: November 29, 2007
Last updated: April 1, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2009 |
| Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |